(R)-Duloxetine (CAS 116539-60-7) Market Size, Share & Forecast 2034 | Growth Driven by Enantiopure APIs, Neuropathic Pain Therapies & Generic Pharmaceutical Expansion
Global (R)-Duloxetine (CAS 116539-60-7) market was valued at USD 1.87 billion in 2025 and is projected to reach USD 3.64 billion by 2034, exhibiting a remarkable CAGR of 6.8% during the forecast period.  (R)-Duloxetine (CAS 116539-60-7) is the pharmacologically active enantiomer of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI) widely used in the treatment of major...
0 Commentarios 0 Acciones 120 Views 0 Vista previa